Maximizing the Impact of Human Papillomavirus Vaccination
Suzanne M Garland, Dorothy A Machalek
Clinical Infectious Diseases | OXFORD UNIV PRESS INC | Published : 2017
S. M. G. has received institutional grant support from Merck, GSK, and the Commonwealth Department of Health; payment for lectures from MSD, Sanofi Pasteur MSD, and Merck; consultancy fees from Merck, Abbott Nutrition, and MSD; and institutional support toward the Royal Women's Hospital HPV Research fund from the Merck HPV Advisory Board Meeting in November 2015. D. A. M. reports no potential conflicts. Both authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.